32° Snow

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition
STOCKING STUFFER CONTEST

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

9 Meters Biopharma, Inc. - Common Stock (NQ:NMTR)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 9 Meters Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

9 Meters Biopharma to Participate at the 44th European Society for Clinical Nutrition and Metabolism (ESPEN) Congress

September 01, 2022

Via ACCESSWIRE

9 Meters Biopharma to Participate in the Citi 17th Annual BioPharma Conference

August 31, 2022

Via ACCESSWIRE

9 Meters Biopharma Provides Business Update and Reports Financial Results for Second Quarter 2022

August 15, 2022

Via ACCESSWIRE

Around $2 Million Bet On This Stock? 4 Penny Stocks Insiders are Buying ↗

July 11, 2022

The US economy added 372,000 payrolls in June, following a revised 384,000 growth in May. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 11, 2022

We're diving into all of the latest stock news on Monday with our breakdown of the biggest pre-market stock movers for today!

Via InvestorPlace

Why Is Twitter Down By More Than 5%? 22 Stocks Moving In Monday's Pre-Market Session ↗

July 11, 2022

Gainers Inpixon (NASDAQ: INPX) rose 25.8% to $0.2305 in pre-market trading after gaining more than 22% on Friday.

Via Benzinga

9 Meters Biopharma to Participate in the William Blair Biotech Focus Conference 2022

July 06, 2022

RALEIGH, NC / ACCESSWIRE / July 6, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced...

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel Syndrome

June 30, 2022

Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel Syndrome

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel Syndrome

June 30, 2022

RALEIGH, NC / ACCESSWIRE / June 30, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today...

From 9 Meters Biopharma

Via AccessWire

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 23, 2022

Via Benzinga

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session ↗

June 30, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 22, 2022

Good morning! It's time to start off another busy day of trading with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday ↗

June 24, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...

Via Benzinga

Why Are 9 Meters Biopharma Shares Plunging Today? ↗

June 21, 2022

9 Meters Biopharma Inc (NASDAQ: NMTR) completed a pre-specified interim analysis for the Phase 3 study of larazotide for patients with celiac disease who continue to experience gastrointestinal...

Via Benzinga

67 Biggest Movers From Yesterday ↗

June 22, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.

Via Benzinga

9 Meters Biopharma Announces Interim Analysis of Phase 3 Study of Larazotide for Celiac Disease Does Not Support Trial Continuation

June 21, 2022

RALEIGH, NC / ACCESSWIRE / June 21, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today...

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma to Participate in the 2022 BIO International Convention

June 13, 2022

RALEIGH, NC / ACCESSWIRE / June 13, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases,...

From 9 Meters Biopharma

Via AccessWire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 20, 2022

Via Benzinga

9 Meters Biopharma to Exhibit at Digestive Disease Week 2022

May 19, 2022

RALEIGH, NC / ACCESSWIRE / May 19, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced...

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma Presents Preclinical Data at the 2022 American Thoracic Society International Conference on the Use of Larazotide in Idiopathic Pulmonary Fibrosis

May 18, 2022

RALEIGH, NC / ACCESSWIRE / May 18, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced...

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2022

May 16, 2022

- On track to report Phase 2 data for vurolenatide for short bowel syndrome and Phase 3 interim analysis for celiac disease in June - Cash balance as of March 31, 2022, of $37.2 million is expected to...

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma to Present at the H.C. Wainwright Global Investment Conference and the LifeSci Partners Immunology & Inflammation Symposium

May 05, 2022

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma and Celiac.com Announce Collaboration to Support Clinical Trial Enrollment in 9 Meter's Phase 3 Study for Celiac Disease

April 20, 2022

RALEIGH, NC and SANTA ROSA, CA / ACCESSWIRE / April 20, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating...

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma Announces Allowance of Patent for Anti-GIP Monoclonal Antibody NM-136 for the Treatment of Serious Metabolic Conditions

April 13, 2022

RALEIGH, NC / ACCESSWIRE / April 13, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases,...

From 9 Meters Biopharma

Via AccessWire

Topics Intellectual Property

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

Recap: 9 Meters Biopharma Q4 Earnings ↗

March 23, 2022

9 Meters Biopharma (NASDAQ:NMTR) reported its Q4 earnings results on Wednesday, March 23, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2021

March 23, 2022

RALEIGH, NC / ACCESSWIRE / March 23, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today...

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma to Present at the Maxim Group 2022 Virtual Growth Conference

March 21, 2022

RALEIGH, NC / ACCESSWIRE / March 21, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases,...

From 9 Meters Biopharma

Via AccessWire

9 Meters Biopharma to Present at the Oppenheimer 32nd Annual Healthcare Conference

March 09, 2022

RALEIGH, NC / ACCESSWIRE / March 9, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases,...

From 9 Meters Biopharma

Via AccessWire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

9 Meters Biopharma, Inc. - Common Stock (NQ:NMTR)

All News about 9 Meters Biopharma, Inc. - Common Stock

Sections

Services